Hogan Lovells International LLP‘s Dutch healthcare and life sciences practice leverages its international presence and collaborations with other offices in order to advise global clients on global regulatory surveillance issues. Regulatory specialist Hein van den Bos and patent expert Bert Oosting assists global pharmaceutical companies with patent enforcements of innovative products and regulatory advice, including pricing, reimbursement and tendering issues. The experienced Ruud van der Velden represents companies in high-tech and life sciences industries in multi-jurisdiction patent and trade secret litigation and Joke Bodewits resolves compliance and enforcement issues, dealing with cybersecurity incidents and international data transfers. He also drafts commercial contracts, including IT licensing agreements and distribution agreements. Senior associate Chantal Van Dam supports Bodewits on global data protection strategies. Senior associate Karen Jelsma and recently promoted counsel Dirk-Jan Ridderinkhof add further depth and dimension to the practice, with the former focusing on product liability matters in the life sciences area, and the latter a key patent litigation contact. The team also supports global biotech companies with Dutch market entry strategies. Gertjan Kuipers was a new arrival in April 2023 from De Brauw Blackstone Westbroek.

Loyens & Loeff is ‘well equipped to handle healthcare and health insurance matters’, with a particular skill in combining legal and tax knowledge when advising local care providers and global pharmaceutical companies. The team also frequently advises clients on competition law and the governance aspects of partnerships in the healthcare industry, concerning individual care providers or the joint purchasing of medicines by hospitals and healthcare insurers. Tom van Helmond focuses on regulatory, litigation and competition work and Kim Lucassen specialises in contracts and data protection in both the healthcare and life sciences areas. New York-based Vincent van der Lans is strategically placed to assist multinational life sciences corporations and investment firms with international tax matters. Marc Wiggers is sought out by healthcare insurers and providers for contentious and non-contentious assistance. At associate level, Dieuwke Hooft Graafland, who is an expert in regulatory law and represents clients in insurance and financing disputes; data protection and privacy law specialist Céline Van Waesberge, who works for clients in the pharmaceutical, medical devices and DNA sequencing fields; and Aurélie Mingels, who provides clients with purchasing strategies and advises on tender procedures, are the names to note.

NautaDutilh’s healthcare and life sciences team is ‘pragmatic to work with and focused on optimising the best commercial deal’ and acts for high-profile clients on the full scope of work. Ruud Smits acts for biotech, med-tech and pharmaceutical companies on corporate mandates, including financing strategies and M&A and IP specialist Anne Marie Verschuur represents international biopharmaceutical companies in global patent and trademark disputes. Recently promoted partner Jeroen Boelens works alongside Verschuur in complex IP matters. Stijn Franken focuses on disputes concerning product liability; Wijnand Bossenbroek‘s work covers corporate, and financing advice for pharmaceutical companies; Petra Zijp and Paul van der Bijl specialise in cross-border equity capital market transactions and debt offerings with listings on Euronext Amsterdam and abroad. New York-based Rebecca Pinto strengthens the firm’s global relationships and adds an extra dimension to the scope of the practice – dealing with private equity mandates in the life sciences and technology sectors. Sybren de Beur further strengthens the team's corporate expertise in the life sciences space.

Amsterdam-based healthcare specialist Joris Rijken and Eindhoven-based life sciences practitioner Barbara Mutsaers lead AKD’s healthcare and life sciences practice. Rijken assists healthcare advisers with care procurements and contracts with various government bodies and provides regulatory advice on medical scientific research. Mutsaers frequently deals with sector specific regulations, including market access and compliance regarding the prohibition of inducements and clinical trials; she also handles various agreements, namely R&D and license agreements. The team frequently works on entry strategies for foreign clients in the life sciences sector.

BarentsKrans’ multi-disciplinary industry-focused healthcare and life sciences practice deals with the whole chain of life sciences mandates, ranging from disputes concerning regulation and patents for the entry of pharmaceutical products to clinical trial agreements and product liability. Healthcare specialist Tim Raats focuses on competition and procurement law, advising hospitals on merger control issues and obtaining clearances; he also advises mental health providers on municipal tendering. The team, including IP and technology specialist Jaap Bremer, deals with contracts pertaining to medical devices and the launch of biosimilar products. In February 2023, former practice head Marleen van den Horst left for La Gro Geelkerken Advocaten.

Bird & Bird‘s healthcare and life sciences practice is known for its IP focus, with practitioners ‘very strong in chemical and pharmaceutical patent matters (including regulatory issues)’. Hague-based Marc van Wijngaarden co-heads the Dutch life sciences group, specialising in patent litigation, compliance, corporate and competition laws for pharmaceutical, biotech and medical devices companies. Fellow co-head Michiel Wurfbain advises on cross-border M&A deals, public-to-private transactions, financial matters and corporate governance. Armand Killan is an expert in patent disputes involving medical devices and pharmaceutical clients. Amsterdam-based Wouter Pors focuses on complex contentious matters concerning regulatory issues and IP disputes with an EU-wide dimension. Competition & EU Law expert Janneke Kohlen assists clients with public procurement, merger control, cartel cases and abuse of dominance matters. Patent and trade secret issues are the main focus of Tjibbe Douma's practice. Counsel Peter Van Gemert and associate Hester Borgers are key patent litigation and regulatory specialists in the team.

CMS leverages its global life sciences group in order to provide clients with practical and commercial solutions. The team works on contentious and non-contentious mandates, representing healthcare companies in IP infringement cases and assisting biotech companies with incorporation and IPOs. Regulatory practice head Ellen Gielen advises international life sciences companies on a range of product issues including manufacturing and distribution, pricing and reimbursement, and advertising. Gertie Lintjens brings further industry-specific experience, assisting with business models and R&D projects.

De Brauw Blackstone Westbroek‘s healthcare and life sciences practice covers a wide range of matters for clients including global pharmaceutical and biotech companies, health clinics and investors. Tobias Cohen Jehoram is sought out for expertise in Supreme Court patent litigation, dealing with landmark IP decisions in the life sciences field. Reinier Kleipool is the key contact for listed companies and large multinationals, who require advise on M&A, corporate governance, investments and anti-takeover responses. Lennard Keijzer specialises in complex private equity issues, including assisting specialist healthcare investment firms in investments and divestments in the health sector. Associate Bertrand ter Woort adds depth to the patent litigation practice. Since research concluded, Gertjan Kuipers and Carlos van Staveren left the firm.

Houthoff‘s strength in the healthcare space is evident in its advice to providers, including hospitals and private clinics, on a full range of mandates. Weyer VerLoren van Themaat handles high-profile and complex mergers involving large private health clinics, which require extensive regulatory knowledge. Litigator Huib Lebbing frequently undertakes cases concerning contractual liability within the healthcare sector, where he acts as defence counsel. Freeke Heijne focuses on healthcare laws and regulation compliance. EU and competition law specialist Greetje van Heezik assists clients with regulations concerning both medicinal products and medical devices. Senior associate Murat Duman advises clients on investigations by the Dutch competition authority and the Dutch healthcare authority as well as merger control proceedings before such authorities. The team also advises investment companies on investments in healthcare companies.

Van Doorne’s multi-disciplinary healthcare and life sciences team handles traditional regulatory and litigation matters in the pharmaceutical arena and data protection and IT in the digital health-tech space for domestic and international clients. Healthcare law expert Willemien Bischot supports hospitals and healthcare providers with matters relating to the elderly and special needs space in complying with regulations. Bischot is entrusted with a full range of mandates, including financing, corporate governance and M&A. Life sciences specialist Dimitri van Hoewijk advises private equity firms, suppliers and manufacturers of medicinal products, start-ups and medical devices companies on M&A. Counsel Louis Jonker assists clients in the healthcare industry with IT and outsourcing projects. Healthcare providers entrust Steven Sterk with employment law matters, including reorganisations and dismissals. Corporate law focused duo Nick Suurmond and Siego Boslooper and tax lawyer Danielle Westerhoff are key supporting associates.

The litigation-focused life sciences practice at Vondst Advocaten N.V is regularly called upon by major pharmaceutical and medical devices companies. Otto Swens is the key name for patent and regulatory disputes, as well as pricing, parallel imports, reimbursements and product liability issues. Patent litigators Ricardo Dijkstra and Arvid Van Oorschot are also noted.

Jointly led by healthcare expert Fenna van Dijk and life sciences specialist Maarten Schut, Kennedy Van der Laan's team handles the full breadth of mandates across the healthcare and life sciences segments. Combining a corporate background with a focus on healthcare, Van Dijk advises on market entry, licenses, clinical research, PPPs and drafting contracts with medical devices companies; she played a key role in the vaccine strategy concerning the Covid-19 pandemic. IP expert Schut advises multinational companies including Nutreco and Syngenta and not-for-profit institutions on conflicts relating to R&D and licensing. With the addition of Joran Spauwen, the practice has gained a specialist in IP-focused transactions in the advanced technologies sector, assisting healthcare service providers with medical devices regulation and negotiating contracts with AI suppliers. He also links the M&A practice to the healthcare and life sciences practice, focusing on innovative companies investing in the health tech industry. Counsel Sophie Van Loon specialises in contract drafting, advisory work and litigation within the life sciences field and associate Eline Lam focuses on corporate, healthcare and regulatory law.

Maverick Advocaten N.V. is known for its competition law and litigation work concerning regulatory issues in the healthcare sector. A ‘To-the-point adviser who understands the complexity of decision-making processes within healthcare organisations’, Martijn Van De Hel advises healthcare organisations on the competition law aspects of setting up a cooperation and represents healthcare organisations in the approval proceedings at the NZA and ACM in case of a merger, takeover or the creation of a joint venture. With ‘overwhelming knowledge of the healthcare business’, Diederik Schrijvershof is sought out by both healthcare and pharmaceutical sector companies for advice on competition law and regulation.

Representing public sector bodies in disputes is a key strength of The Hague-based Pels Rijcken & Droogleever Fortuijn NV‘s healthcare team. Elisabeth Pietermaat leads the public sector team, representing the Dutch Healthcare Authority and national regulatory authorities on issues related to the financing and macro-financing of healthcare. Experienced litigator Wemmeke Wisman acts for public sector clients in disputes involving the quality of healthcare and medicines – working on cases intersecting public and private law. Marije Batting heads the administrative law department, focusing on quality of care in the life sciences field, namely working on the approval of medicines, pricing and reimbursements. Associate Jorrit van de Weide represents public authorities and semi-public organisations on bankruptcies and continuities of healthcare providers. Associate Anna van Gijssel acts for municipalities in proceedings concerning the fraud in the healthcare space. The team also works with Dutch healthcare insurance companies.